Utama › Diabetes Jenis 2 › California › Los Angeles
Kajian klinikal Diabetes Jenis 2 di Los Angeles, CA
16 kajian untuk Diabetes Jenis 2 sedang mencari peserta di lokasi dalam dan sekitar Los Angeles (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Mengambil pesertaFasa 3
- Downtown LA Res Ctr. Inc., Los Angeles
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Mengambil pesertaFasa 3
- Inglewood Clinical, Los Angeles
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Mengambil pesertaFasa 3
- AURORA-2 Clinical Site, Los Angeles
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Mengambil pesertaFasa 2
- Los Angeles Institute for Metabolic Research, Los Angeles
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Mengambil pesertaFasa 2
- Los Angeles Institute for Metabolic Research, Los Angeles
- Velocity Clinical Research, Los Angeles, Los Angeles
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Mengambil pesertaFasa 3
- VAGLAHS Clinical Research Center (CRC), Los Angeles
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Mengambil pesertaFasa 3
- Research Site, Los Angeles
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Mengambil pesertaFasa 3
- Division of Endocrinology, Diabetes, and Metabolism, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Mengambil peserta
- University of Southern California, Los Angeles
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Mengambil peserta
- University of Southern California, Los Angeles
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Mengambil pesertaKajian pemerhatian
- Children's Hospital Los Angeles, Los Angeles
Type 2 Continuous Glucose Monitoring Academy
Mengambil peserta
- Children's Hospital Los Angeles, Los Angeles
New T-UP: Engaging Vulnerable Students in Diabetes Prevention
Mengambil peserta
- University of California, Los Angeles, Los Angeles
Implementation of Team Clinic for Type 2 Diabetes (TCT2)
Mengambil peserta
- Children's Hospital Los Angeles, Los Angeles
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
Mengambil peserta
- Angel City Research, Los Angeles
- Clemente Clinical Research, Los Angeles
DETERMINE: Detemir vs NPH
Mengambil pesertaFasa 2
- University of California, Los Angeles, Los Angeles
Kajian Diabetes Jenis 2 di bandar lain
- San Antonio, TX37 kajian
- Houston, TX31 kajian
- Orlando, FL25 kajian
- Boston, MA20 kajian
- Chicago, IL19 kajian
- Dallas, TX19 kajian
- Miami, FL19 kajian
- Columbus, OH18 kajian
- Las Vegas, NV18 kajian
- San Diego, CA17 kajian
- Atlanta, GA17 kajian
- Birmingham, AL16 kajian
Kajian lain di Los Angeles
- Kanser Paru-paru Bukan Sel Kecil87 kajian
- Kanser (semua jenis)74 kajian
- Kanser Payudara73 kajian
- Kanser Prostat61 kajian
- Kanser Kolorektal59 kajian
- Kanser Metastatik57 kajian
- Kanser Ovari50 kajian
- Kanser Paru-paru45 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher42 kajian
- Kanser Pankreas35 kajian
- Kanser Endometrium34 kajian
- Melanoma34 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.